Recently the importance of CXCL10 in the pathogenesis of non-segmental vitiligo (NSV) and autoimmune thyroid disorders (AITD) has been shown. No data are present about chemokines CXCL10 (Th1 prototype) and CCL2 (Th2 prototype) circulating levels in NSV patients with/without thyroiditis (AT). Serum CXCL10 and CCL2 have been measured in 50 consecutive NSV patients, in 40 consecutive patients with NSV and AT (NSV + AT), in 50 sex- and age-matched controls without AT (control 1) and in 40 sex- and agematched patients with AT without NSV (control 2). Serum CXCL10 levels were significantly higher in control 2, than in control 1 (P=0.001; ANOVA). NSV patients have serum CXCL10 levels significantly higher than control 1, or control 2 (P=0.001). NSV + AT patients have serum CXCL10 levels higher than control 1, or 2 (P b 0.001), and than NSV (P=0.01). In conclusion, we first demonstrate high serum CXCL10 in NSV patients, overall in presence of AT and hypothyroidism, suggesting the importance of a common Th1 immune response in their immune-pathogenesis. To evaluate if serum CXCL10 might be used as a clinical marker of NSV and/or AT further studies are needed.

Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis / Martina Ferrari, Silvia; Fallahi, Poupak; Santaguida, MARIA GIULIA; Virili, Camilla; Ruffilli, Ilaria; Ragusa, Francesca; Centanni, Marco; Antonelli, Alessandro. - In: AUTOIMMUNITY REVIEWS. - ISSN 1568-9972. - 16:9(2017), pp. 946-950. [10.1016/j.autrev.2017.07.006]

Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis

Giulia Santaguida;Camilla Virili;Marco Centanni;
2017

Abstract

Recently the importance of CXCL10 in the pathogenesis of non-segmental vitiligo (NSV) and autoimmune thyroid disorders (AITD) has been shown. No data are present about chemokines CXCL10 (Th1 prototype) and CCL2 (Th2 prototype) circulating levels in NSV patients with/without thyroiditis (AT). Serum CXCL10 and CCL2 have been measured in 50 consecutive NSV patients, in 40 consecutive patients with NSV and AT (NSV + AT), in 50 sex- and age-matched controls without AT (control 1) and in 40 sex- and agematched patients with AT without NSV (control 2). Serum CXCL10 levels were significantly higher in control 2, than in control 1 (P=0.001; ANOVA). NSV patients have serum CXCL10 levels significantly higher than control 1, or control 2 (P=0.001). NSV + AT patients have serum CXCL10 levels higher than control 1, or 2 (P b 0.001), and than NSV (P=0.01). In conclusion, we first demonstrate high serum CXCL10 in NSV patients, overall in presence of AT and hypothyroidism, suggesting the importance of a common Th1 immune response in their immune-pathogenesis. To evaluate if serum CXCL10 might be used as a clinical marker of NSV and/or AT further studies are needed.
2017
Vitiligo; autoimmune thyroiditis; CXCL10; CCL2; chemokines
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis / Martina Ferrari, Silvia; Fallahi, Poupak; Santaguida, MARIA GIULIA; Virili, Camilla; Ruffilli, Ilaria; Ragusa, Francesca; Centanni, Marco; Antonelli, Alessandro. - In: AUTOIMMUNITY REVIEWS. - ISSN 1568-9972. - 16:9(2017), pp. 946-950. [10.1016/j.autrev.2017.07.006]
File allegati a questo prodotto
File Dimensione Formato  
Centanni_Non-segmental-vitiligo.pdf

Open Access dal 03/09/2022

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 253.79 kB
Formato Adobe PDF
253.79 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1204649
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 31
social impact